<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="49">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04355741</url>
  </required_header>
  <id_info>
    <org_study_id>COVID19_Microbiota</org_study_id>
    <nct_id>NCT04355741</nct_id>
  </id_info>
  <brief_title>Gut Microbiota, &quot;Spark and Flame&quot; of COVID-19 Disease</brief_title>
  <official_title>Gut Microbiota, &quot;Spark and Flame&quot; of COVID-19 Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Nova de Lisboa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NOVA Medical School of Universidade NOVA de Lisboa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Hospitalar Universitário São João</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CUF Academic and Research Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital CUF Infante Santo, S.A.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro de Medicina Laboratorial Germano de Sousa, S.A.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CINTESIS - Center for Health Technology and Services Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Nova de Lisboa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elderly, hypertension, diabetes and cardiovascular diseases are risk factors for COVID-19
      morbility and mortality. However, the real reason for this is not yet understood. It is well
      documented that gut microbiota has a critical role in health, particularly in the immune
      system and therefore, we propose that gut microbiota composition could affect vulnerability
      and disease outcomes of COVID-19.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to explore this hypothesis, we will analyse the gut microbiota of SARSCoV-2 infected
      patients categorized according to location: [1] ambulatory (self-isolation at home), [2] ward
      and [1] ICU; and severity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 20, 2020</start_date>
  <completion_date type="Actual">July 16, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in gut microbiota composition between COVID-19 patients with different degrees of disease severity.</measure>
    <time_frame>Stool samples of COVID-19 patients will be collected after subject enrollment (single point collection)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in gut microbiota composition between COVID-19 patients in relation to mortality.</measure>
    <time_frame>Through study completion, an average of 3 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in gut microbiota composition between COVID-19 patients in relation to length of stay in hospitals.</measure>
    <time_frame>Through study completion, an average of 3 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in gut microbiota composition between COVID-19 patients in relation to duration of mechanical ventilation.</measure>
    <time_frame>Through study completion, an average of 3 months.</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">115</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Ambulatory</arm_group_label>
    <description>Patients that are self-isolated at home</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ward</arm_group_label>
    <description>Patients that are in an isolated room at the hospital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU</arm_group_label>
    <description>Patients that are in the ICU of the hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exposure</intervention_name>
    <description>Individuals with SARS-CoV-2 exposure and COVID-19 symptoms.</description>
    <arm_group_label>Ambulatory</arm_group_label>
    <arm_group_label>ICU</arm_group_label>
    <arm_group_label>Ward</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        COVID-19 patients admitted to Portuguese hospitals.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults of 18 years and above.

          -  COVID-19 patients.

        Exclusion Criteria:

          -  None.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Conceição Calhau, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NOVA Medical School of Universidade NOVA de Lisboa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pedro Póvoa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital São Francisco Xavier</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina Granja, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Hospitalar Universitário São João</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria JR Sousa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro de Medicina Laboratorial Germano de Sousa, S.A.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Leal, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Centro de Medicina Laboratorial Germano de Sousa, S.A.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital CUF Infante Santo, S.A.</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de São Francisco Xavier</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Universitário São João</name>
      <address>
        <city>Oporto</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>August 21, 2020</last_update_submitted>
  <last_update_submitted_qc>August 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Gut microbiota</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

